Relapse after treatment of pediatric hodgkin lymphoma: Outcome and role of surveillance after end of therapy

Pediatric Blood and Cancer

Volumn 60, Issue 9, 2013, Pages 1458-1463

  Friedmann, Alison M ^a   Wolfson, Julie A ^b   Hudson, Melissa M ^c   Weinstein, Howard J ^a   Link, Michael P ^d   Billett, Amy ^e   Larsen, Eric C ^f   Yock, Torunn ^a   Donaldson, Sarah S ^d   Marcus, Karen ^e   Krasin, Matthew J ^c   Howard, Scott C ^c   Metzger, Monika L ^c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^c ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^d STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^e DANA FARBER CANCER INSTITUTE   (United States)

^f Maine Children's Cancer Program Scarborough   (United States)

Author keywords

Childhood; Hodgkin lymphoma; Outcome; Pediatric; Relapse; Surveillance

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; CHILD; CONTROLLED STUDY; FEMALE; FEVER; FOLLOW UP; HODGKIN DISEASE; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NIGHT SWEAT; OVERALL SURVIVAL; PAIN; PHYSICAL EXAMINATION; POSITRON EMISSION TOMOGRAPHY; PRESCHOOL CHILD; PRIORITY JOURNAL; PRURITUS; SCHOOL CHILD; THORAX RADIOGRAPHY; TREATMENT OUTCOME; WEIGHT REDUCTION;

CHILDHOOD; HODGKIN LYMPHOMA; OUTCOME; PEDIATRIC; RELAPSE; SURVEILLANCE;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HODGKIN DISEASE; HUMANS; MALE; RECURRENCE; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84880329783     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.24568     Document Type: Article

References (18)

1. El-Galaly TC, Mylam KJ, Brown P, et al. Positron emission tomography/computed tomography surveillance in patients with Hodgkin lymphoma in first remission has a low positive predictive value and high costs. Haematologica 2012; 97:931-936.
2. Levine JM, Weiner M, Kelly KM. Routine use of PET scans after completion of therapy in pediatric Hodgkin disease results in a high false positive rate. J Pediatr Hematol Oncol 2006; 11:711-714.
3. Meany HJ, Gidvani VK, Minniti CP. Utility of PET scans to predict disease relapse in pediatric patients with Hodgkin lymphoma. Pediatr Blood Cancer 2007; 48:399-402.
4. Rhodes MM, Delbeke D, Whitlock JA, et al. Utility of FDG-PET/CT in follow-up of children treated for Hodgkin and non-Hodgkin lymphoma. J Pediatr Hematol Oncol 2006; 28:300-306.
5. Donaldson SS, Hudson MM, Lamborn KR, et al. VAMP and low-dose, involved-field radiation for children and adolescents with favorable, early-stage Hodgkin's disease: Results of a prospective clinical trial. J Clin Oncol 2002; 20:3081-3087.
6. Donaldson SS, Link MP, Weinstein HJ, et al. Final results of a prospective clinical trial with VAMP and low-dose involved-field radiation for children with low-risk Hodgkin's disease. J Clin Oncol 2007; 25:332-337.
7. Friedmann AM, Hudson MM, Weinstein HJ, et al. Treatment of unfavorable childhood Hodgkin's disease with VEPA and low-dose, involved-field radiation. J Clin Oncol 2002; 20:3088-3094.
8. Hudson MM, Krasin M, Link MP, et al. Risk-adapted, combined-modality therapy with VAMP/COP and response-based, involved-field radiation for unfavorable pediatric Hodgkin's disease. J Clin Oncol 2004; 22:4541-4550.
9. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53:457-481.
10. Biasotti S, Garaventa A, Padovani P, et al. Role of active follow-up for early diagnosis of relapse after elective end of therapies. Pediatr Blood Cancer 2005; 45:781-786.
11. Torrey MJ, Poen JC, Hoppe RT. Detection of relapse in early-stage Hodgkin's disease: Role of routine follow-up studies. J Clin Oncol 1997; 15:1123-1130.
12. Radford JA, Eardley A, Woodman C, et al. Follow up policy after treatment for Hodgkin's disease: Too many clinic visits and routine tests? A review of hospital records. Br Med J 1997; 314:343-346.
13. Voss SD, Lu C, Constine LS, et al. Surveillance computed tomography imaging and detection of relapse in intermediate- and advanced-stage pediatric Hodgkin lymphoma: A report from the Children's Oncology Group. J Clin Oncol 2012; 30:2635-2640.
14. Zinzani PL, Stefoni V, Tani M, et al. Role of [18F]fluorodeoxyglucose positron emission tomography scan in the follow-up of lymphoma. J Clin Oncol 2009; 27:1781-1787.
15. Jerusalem G, Beguin Y, Fassotte MF, et al. Early detection of relapse by whole-body positron emission tomography in the follow-up of patients with Hodgkin's disease. Ann Oncol 2003; 14:123-130.
16. Goldschmidt N, Or O, Klein M, et al. The role of routine imaging procedures in the detection of relapse of patients with Hodgkin lymphoma and aggressive non-Hodgkin lymphoma. Ann Hematol 2011; 90:165-171.
17. Cheson B. The case against heavy PETing. J Clin Oncol 2009; 27:1742-1743.
18. Dryver ET, Jernstrom H, Tompkins K, et al. Follow-up of patients with Hodgkin's disease following curative treatment: The routine CT scan is of little value. Br J Cancer 2003; 89:482-486.